Home › NDC Lookup › RxCUI directory › RxCUI 1716215

Patiromer 8400 MG Powder for Oral Suspension [Veltassa] — RxCUI 1716215

Name: Patiromer 8400 MG Powder for Oral Suspension [Veltassa] (RxCUI 1716215)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 1716215 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1716215

Official namePatiromer 8400 MG Powder for Oral Suspension [Veltassa]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asVeltassa 8.4 GM Powder for Oral Suspension; Veltassa 8400 MG Powder for Oral Suspension

FDA products mapped4

Package NDCs mapped6

Reported Medicaid activity (SDUD)13,474 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Patiromer: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Think of Veltassa as a sponge that you swallow. It travels through your gut, latches onto excess potassium in your intestines, and carries it out of your body in your stool. It nev...
What exactly is Veltassa doing in my body?
Mix the packet of powder into about a third of a cup of water — or a soft food like applesauce or yogurt — right before you take it. Stir it well, drink it immediately, and if powd...
How do I mix and take this medication correctly?

📖 Read our full Patiromer guide →

🕸️ Concept Web — How Patiromer 8400 MG Powder for Oral Suspension [Ve... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Patiromer 8400 MG Powder for Oral Suspension [Veltassa] RxCUI 1716215 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Patiromer 1716203 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Veltassa 1716210 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Patiromer Powder for Oral Suspension 1716208 SCDF
- Patiromer Oral Powder Product 1716206 SCDG
- Patiromer Oral Product 1716207 SCDG
- Patiromer Powder for Oral Suspension [Veltassa] 1716212 SBDF
- Veltassa Oral Powder Product 1716213 SBDG
- Veltassa Oral Product 1716214 SBDG
- Powder for Oral Suspension 1540456 DF
- Oral Powder Product 1294711 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Patiromer 8400 MG Powder for Oral Suspension 1716209 SCD
- Patiromer 8400 MG 1716205 SCDC
- Patiromer 8400 MG [Veltassa] 1716211 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Patiromer 8400 MG Powder for Oral Suspension SCD · 1716209
Patiromer 8400 MG SCDC · 1716205
Patiromer Powder for Oral Suspension SCDF · 1716208
Patiromer Oral Powder Product SCDG · 1716206
Patiromer Oral Product SCDG · 1716207

Brand-Name Concepts

Patiromer 8400 MG [Veltassa] SBDC · 1716211
Patiromer Powder for Oral Suspension [Veltassa] SBDF · 1716212
Veltassa Oral Powder Product SBDG · 1716213
Veltassa Oral Product SBDG · 1716214
Veltassa BN · 1716210

📦 FDA Products & Package NDCs

4 products · 6 package NDCs

6 package NDCs map to RxCUI 1716215 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
53436-0010-60	60 PACKET in 1 CARTON (53436-010-60) / 1 POWDER, FOR SUSPEN...	VELTASSA	Vifor Pharma, Inc.	2024-10-02
53436-0084-04	4 PACKET in 1 CARTON (53436-084-04) / 1 POWDER, FOR SUSPENS...	VELTASSA	Vifor Pharma, Inc.	2015-10-23
53436-0084-30	30 PACKET in 1 CARTON (53436-084-30) / 1 POWDER, FOR SUSPEN...	VELTASSA	Vifor Pharma, Inc.	2015-10-23
53436-0084-92	4 PACKET in 1 CARTON (53436-084-92) / 1 POWDER, FOR SUSPENS...	VELTASSA	Vifor Pharma, Inc.	2016-05-01
53436-0168-30	30 PACKET in 1 CARTON (53436-168-30) / 1 POWDER, FOR SUSPEN...	VELTASSA	Vifor Pharma, Inc.	2015-10-23
53436-0252-30	30 PACKET in 1 CARTON (53436-252-30) / 1 POWDER, FOR SUSPEN...	VELTASSA	Vifor Pharma, Inc.	2015-10-23

Observed labelers: Vifor Pharma, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.